Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V565 in Active Crohn's Disease
NCT02976129Phase 2Completed
- Sponsor
- VHsquared Ltd.
- Start
- Dec 2016
- Primary completion
- Mar 2019
- Modality
- Antibody Conjugates, Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of V565 in Crohn's disease, sponsored by VHsquared Ltd.. Started Dec 2016; status: completed.
02
Drugs
V565
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02976129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976129.